Scholtz & Company’s Xylem XYL Stock Holding History

Scholtz & Company’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,450	Closed	-$213K	–	78
2014 Q2	$213K	Buy	+5,450	New	+$204K	0.2%	77

Other funds holding XYL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sasco Capital Fairfield, Connecticut $668M AUM 12.79% 1-Year Est. Return

Scholtz & Company's XYL Position: Q3 2014 in Review

Scholtz & Company sold out of Xylem (XYL) in Q3 2014, closing a stake of 5,450 shares — an estimated $213K sold.

Scholtz & Company first reported a position in XYL in Q2 2014 and held it in 1 quarter. The position peaked at $213K in Q2 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

Scholtz & Company reported no remaining Xylem position as of Q3 2014 after selling out during the quarter.
Scholtz & Company sold 5,450 Xylem shares in Q3 2014, an estimated $213K.
Scholtz & Company first reported a position in Xylem in Q2 2014 and held it in 1 quarter.
Scholtz & Company's Xylem position peaked at $213K in Q2 2014.
439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on Scholtz & Company's 13F filing for Q3 2014, filed 13 Nov 2014.